Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer-Reference-Cited by-同舟云学术

Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer

Published:2014-03-06 Issue:3 Volume:9 Page:211-220
ISSN:1555-4309
Container-title:Contrast Media & Molecular Imaging
language:en
Short-container-title:Contrast Media Mol. Imaging

Author:

Evazalipour Mehdi¹²,D'Huyvetter Matthias³⁴,Tehrani Bahram Soltani⁵,Abolhassani Mohsen¹,Omidfar Kobra⁶,Abdoli Shahriyar⁷,Arezumand Roghaye⁸,Morovvati Hamid⁹,Lahoutte Tony³¹⁰,Muyldermans Serge¹¹¹²,Devoogdt Nick³

Affiliation:

1. Department of Immunology; Pasteur Institute of Iran; Tehran Iran

2. Department of Pharmaceutical Biotechnology, School of Pharmacy; Guilan University of Medical Sciences; Rasht Iran

3. In vivo Cellular and Molecular Imaging Laboratory; Vrije Universiteit Brussel; Brussels Belgium

4. Radiobiology Unit, Molecular and Cellular Biology Expert Group; Belgian Nuclear Research Center (SCK•CEN); Mol Belgium

5. Cellular and Molecular Research Center, Faculty of Medicine; Guilan University of Medical Sciences; Rasht Iran

6. Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute; Tehran University of Medical Sciences; Tehran Iran

7. Department of Virology; Pasteur Institute of Iran; Tehran Iran

8. Department of Molecular Medicine; Pasteur Institute of Iran; Tehran Iran

9. Animal Facility; Guilan University of Medical Sciences; Rasht Iran

10. Nuclear Medicine Department; UZ Brussel Brussels Belgium

11. Cellular and Molecular Immunology Unit; Vrije Universiteit Brussel; Brussels Belgium

12. Department of Structural Biology, VIB; Brussels Belgium

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmmi.1558/fullpdf

Reference39 articles.

1. Prostate cancer epidemiology in the United States;Brawley;World J Urol,2012

2. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program;Ross;J Clin Oncol,2010

3. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy;Park;AJR Am J Roentgenol,2011

4. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy;Giovacchini;Eur J Nucl Med Mol Imag,2010

5. Evaluation of [18 F]-choline PET/CT for staging and restaging of prostate cancer;Husarik;Eur J Nucl Med Mol Imag,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled Nanobodies;Bioconjugate Chemistry;2024-08-22

2. PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics;Nuclear Medicine and Biology;2024-07

3. RadioLabeling of the Mutant form of Anti-PlGF Nanobody by 99mTc-Tricarbonyl;Iranian Journal of Pharmaceutical Research;2024-06-02

4. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

5. “Nanobody-based immunodiagnostics: A systematic review of nanobody integration in diagnostics and deep insight into electrochemical immunoassays”;Microchemical Journal;2024-01